Legal Commentator
Leading Litigator
Lead Negotiator
Author

“Negotiated over $2.75 Billion in opioid harm reduction for the State of Texas ”

Jeffrey B. Simon Wins 'Best Attorney' Award 4 Years In A Row.

Jeffrey B. Simon is a commentator and founding partner of SIMON GREENSTONE PANATIER, PC. Ranked as one of the Top 10 Personal Injury Attorney's within America and Co-chair of the National Opioid Litigation Conference, Mr. Simon brings together medical, legal, and law experts to reduce the social and economic harms of the opioid pandemic.

Attorney Jeffrey B. Simon Secures $1.8 Billion Opioid Settlement for All Texans

Jeffrey B. Simon announced that he and a committee of trial lawyers, along with the Office of the Texas Attorney General, have reached a historic $1.8 billion settlement for Texas.

Texas reaches $290 million settlement with Johnson & Johnson

A $290 million settlement agreement Tuesday with pharmaceutical giant Johnson & Johnson over what the state claims were deceptive marketing tactics that contributed to the ongoing opioid crisis.

We're Suing Fossil Fuel Companies for $1.15 Billion

This industrially caused environmental disease will cause enormous harm, both in terms of human suffering...

social

My wife, Yasmin Simon, is running for the #txlege #HD108. She wants to serve the public for all the right reasons. Election is Tuesday 3/5. I don’t know how it will go, as only voters can decide. But I know I’ve never admired anyone as much as I do her. #yasminfortexas #love

AL hospital pauses IVF treatments after court ruling on embryos ⁦@AP⁩. Another clear example of harm done when a religious faith is forced upon all as secular law. No med school teaches that embryos are anatomically whole people. #establismentclause

2 men charged with murder in mass shooting at Chiefs’ Super Bowl rally ⁦⁦@KansasCityStar⁩. We need gun safety reform to make guns less available to the criminally minded. I don’t mean YOUR gun (Dear law abiding citizen) but we can be & do more.

Load More

JEFFREY HAS BEEN FEATURED IN

In the news